Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A rational approach to oocyte cryopreservation.

S J Paynter1

  • 1Department of Obstetrics and Gynaecology, Wales College of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. Paynter@cardiff.ac.uk

Reproductive Biomedicine Online
|June 14, 2005
PubMed
Summary

Optimizing cryopreservation protocols is crucial for improving human oocyte survival rates. Understanding cell volume changes during cryoprotectant exposure is key to minimizing damage and enhancing fertility outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membrane permeability coefficients of murine primary neural brain cells in the presence of cryoprotectant.

Cryobiology·2009
Same author

Membrane integrity and development of immature murine cumulus-oocyte complexes following slow cooling to -60 degrees C: the effect of immediate rewarming, plunging into LN2 and two-controlled-rate-stage cooling.

Cryobiology·2006
Same author

Volume changes of mature human oocytes on exposure to cryoprotectant solutions used in slow cooling procedures.

Human reproduction (Oxford, England)·2005
Same author

Developmental potential of murine germinal vesicle stage cumulus-oocyte complexes following exposure to dimethylsulphoxide or cryopreservation: loss of membrane integrity of cumulus cells after thawing.

Human reproduction (Oxford, England)·2003
Same author

Membrane permeability of human oocytes in the presence of the cryoprotectant propane-1,2-diol.

Fertility and sterility·2001
Same author

Current status of the cryopreservation of human unfertilized oocytes.

Human reproduction update·2000

Area of Science:

  • Reproductive Biology
  • Cell Biology
  • Cryobiology

Background:

  • Clinical pregnancies from cryopreserved human oocytes are increasing, but birth rates per thawed oocyte remain low.
  • Current cryopreservation protocols often lack standardization and are based on empirical modifications, leading to variable outcomes.
  • Inappropriate exposure to cryoprotectants during the initial stage of freezing can cause cellular damage via chemical toxicity or osmotic stress.

Purpose of the Study:

  • To investigate the impact of cryoprotectant exposure parameters on cell volume changes in human and murine oocytes.
  • To identify critical factors influencing cellular hydration during cryoprotectant perfusion.
  • To provide insights for optimizing cryopreservation protocols to improve oocyte survival and subsequent birth rates.

Main Methods:

Related Experiment Videos

  • Measurements of oocyte cell volume changes during perfusion with various cryoprotectant solutions.
  • Systematic variation of cryoprotectant type, concentration, and temperature during exposure.
  • Analysis of the relationship between exposure duration, cellular hydration, and potential for cryoinjury.

Main Results:

  • Cell volume changes during cryoprotectant exposure are highly sensitive to the type, concentration, and temperature of the cryoprotectant.
  • Even minor alterations in exposure duration prior to cooling can significantly affect cellular hydration levels.
  • These hydration changes directly influence the oocyte's resilience to subsequent cryopreservation stresses.

Conclusions:

  • Precise control over cryoprotectant exposure conditions is essential for successful human oocyte cryopreservation.
  • Understanding and quantifying cell volume dynamics provides a measurable basis for protocol refinement.
  • Optimized cryoprotectant exposure protocols have the potential to significantly improve oocyte cryopreservation success rates and clinical outcomes.